From: 28/08/2017 to: 08/09/2017 ESO-ESSO-ESTRO Multidisciplinary Course in Oncology for Medical Students, Antwerp, Belgium                                        From: 06/10/2017 to: 07/10/2017 Eastern Europe and Balkan Region Refresher Course on Breast Cancer, Krakow, Poland                                        From: 18/10/2017 to: 20/10/2017 4th Masterclass in Clinical Oncology, Tbilisi, Georgia                                        From: 18/10/2017 to: 18/10/2017 ESO Breast Cancer Observatory, Tehran, Iran                                        From: 27/10/2017 to: 28/10/2017 9th Clinical Oncology Update - Onkologia 2017, Krakow, Poland                                        From: 02/11/2017 to: 04/11/2017 ESO-ESMO Advanced Breast Cancer Fourth International Consensus Conference (ABC4), Lisbon, Portugal                                        From: 02/12/2017 to: 04/12/2017 ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers, Milan, Italy                                        From: 15/12/2017 to: 18/12/2017 6th Arab and Southern European Countries Masterclass in Clinical Oncology, Limassol, Cyprus                                        From: 22/01/2018 to: 26/01/2018 University Post-graduate Course - Clinical Oncology: Sarcomas, Milan, Italy                                        From: 05/02/2018 to: 09/03/2018 University Post-graduate Course - Clinical Oncology: Head & neck cancers, Milan, Italy                                        From: 24/03/2018 to: 29/03/2018 17th ESO-ESMO Masterclass in Clinical Oncology, Nauen OT Groß Behnitz (Berlin area), Germany                                        From: 18/04/2018 to: 22/04/2018 4th ESO-ESMO Latin-American Masterclass in Clinical Oncology, Mexico City, Mexico                                        From: 6/10/2018 to: 8/10/2018 4th ESO-ESMO Breast Cancer in Young Women International Conference, Lugano, Switzerland

ESO Core Faculty



The European School of Oncology wishes to express its gratitude to the following magnificent Experts for sharing the efforts and mission of the School by having contributed in several ESO educational events.
All ESO Core Faculty are highly recommended by the School for lecturing and tutoring in their individual field of expertise.

 

 INDEX
 
Go to:
 
-

Breast Cancer                       

         - Geriatric Oncology         -
Paediatric Oncology
                           
-
Cancer Genetics
         - Gynaecologic Cancer         -
Patient Advocacy
                           
-
Cancer Prevention      
         - Head & Neck Cancer         -
Principles of Clinical Trials and Systemic Therapy
-
Cancer Research          - Haematologic Malignancies         -
Psycho-Oncology
                           
-
Central Nervous System Tumours          - Lung and Other Thoracic Tumours         -
Rare Tumours
-
Cancer of Unknown Primary Tumours Endocrine Tumours and Others
         - Melanoma         - Supportive and Palliative Care
-
Gastro-Intestinal Tumours          - Nursing         -
Tumour Immunology and Immunotheraphy
                           
-
Genitourinary Cancer          - Onco Policy         -
Other
 

         
           
                           
                           


 BREAST CANCER
 Back to top
MEDICAL ONCOLOGY
Matti S. Aapro, Clinique de Genolier, Oncology Dpt., Genolier, Switzerland
Omalkhair Abulkhair, King Abdulaziz Medical City for National Guard, Dept. of Oncology, Riyadh, Saudi Arabia
Stefan Aebi, Lucerne Cantonal Hospital, Dept. of Medical Oncology, Lucerne, Switzerland
Sanaa Al Sukhun, Amman, Jordan
Banu Arun, University of Texas MD Anderson Cancer Center, Breast Medical Oncology and Clinical Cancer Genetics Dpt. Houston, USA
Hatem A. Azim Jr., Innate Pharma, Medical Director, Clinical Development, Marseille, France
Hamdy Abdel Azim, Cairo University Cairo Oncology Center, Dept. of Clinical Oncology, Cairo, Egypt
Jonas Bergh, Karolinska Institute & University Hospital, Department of Oncology-Pathology, Stockholm, Sweden
Semir Beslija, Institute of Oncology, University Clinical Center, Dept. of Medical Oncology, Sarajevo, Bosnia and Herzegovina
Laura Biganzoli, Centro Oncologico "Sandro Pitigliani", Div. di Oncologia Medica, Prato, Italy
David A. Cameron, The University of Edinburgh, Edinburgh Cancer Research Centre Edinburgh, United Kingdom
Fatima Cardoso, Champalimaud Clinical Center, Breast Unit, Lisbon, Portugal
Robert Coleman, Weston Park Hospital, Medical Oncology Academic Unit of Clinical Oncology, Sheffield, United Kingdom
Marco Colleoni, Istituto Europeo di Oncologia, Div. di Oncologia Medica, Milano, Italy
Pier Franco Conte, Istituto Oncologico Veneto, Dipartimento di Oncologia Medica 2, Padova, Italy
John Crown, St Vincent's University Hospital, Dept of Medical Oncology, Dublin, Ireland
Tanja Cufer, University Clinic Golnik, Medical Oncology Unit, Golnik, Slovenia
Giuseppe Curigliano, European Institute of Oncology, Department of Medicine, Division of Experimental Therapeutics, Milano, Italy
Andrea De Censi, E.O. Ospedali Galliera, S.C. Oncologia Medica e Preventiva, Genova, Italy
Suzette Delaloge, Institut Gustave Roussy, Breast Cancer Dpt. Villejuif, France
Rebecca Alexandra Dent, National Cancer Centre Singapore, Division of Medical Oncology, Singapore, Singapore
Angelo Di Leo, Ospedale "Misericordia e Dolce", Unità Operativa di Oncologia Medica "Sandro Pitigliani", Prato, Italy
Nagi S. El Saghir, American University of Beirut Medical Center    Naef K. Basile Cancer Center, Beirut, Lebanon
Alexandru Eniu, Cancer Institute Ion Chiricuta, Dept. of  Breast Cancer, Cluj-Napoca, Romania
Aleksandra Filipovic, London, United Kingdom

Rabab Gaafar, National Cancer Institute, Medical Oncology Dpt., Cairo, Egypt
Karen Gelmon, BC Cancer Agency, Medical Oncology Dpt., Vancouver, Canada
Alessandra Gennari, Galliera Hospital, Department of Medical Oncology, Genoa, Italy
Joseph Gligorov, APHP Tenon, IUC-UPMC, Sorbonne University, Dept. of Medical Oncology, Paris, France
Aron Goldhirsch, European Institute of Oncology, Breast Health Programme, Milano, Italy
Nadia Harbeck, University of Munich (LMU), Breast Centre, Dept. of Obstetrics and Gynaecology, Munich, Germany
Anthony Howell, Christie Oncology/Genesis Breast Cancer Prevention, Medical Oncology and Prevention Dpt., Manchester, United Kingdom
Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, Breast Medicine Service/ Medicine, New York, USA
Catherine M. Kelly, Mater Misericordiae University Hospital, BreastCheck, Dublin 7, Ireland
Hussein Khaled, Cairo University, Dept. of Medical Oncology, Cairo, Egypt
Smruti Koppikar, Bombay Hospital Institute of Medical Sciences, Dept. of Medical Oncology, Mumbai, India
Osman Mansour, National cancer Institute, Cairo University, Dept. of Oncology, Cairo, Egypt
Blaise Nkegoum, University Hospital Center, Pathology and Oncology Dpt., Yaounde, Cameroon
Larry Norton, Memorial Sloan-Kettering Cancer Center, Breast Cancer Medicine Service, New York, USA
Olivia Pagani, Oncology Institute of Southern Switzerland (IOSI), Breast Unit, Bellizona, Switzerland
Shani Paluch-Shimon, Sheba Medical Centre, Oncology Dpt., Ramat Gan, Israel
Ann H. Partridge, Dana-Farber Cancer Institute, Breast Oncology Dpt., Boston, USA
Bernhard Pestalozzi, University Hospital Oncology Clinic, Zurich, Switzerland
Martine J. Piccart, Jules Bordet Institute, Dept. of Medicine, Brussels, Belgium
Xavier Pivot, Centre Hospitalier Jean Minjoz, Dept. of Oncology, Besançon, France
Michael Pollak, Mc Gill University, Dept. of Oncology, Montreal, Quebec, Canada
Razvan Popescu, Hirslanden Klinik Aarau, Tumor Center - Dept. of Medical Oncology, Aarau, Switzerland
Hope S. Rugo, University of California San Francisco, Breast Oncology Clinical Trials Education, San Francisco, USA
Helene Rundqvist, Karolinska Institutet, Dept. of Cell and Molecular Biology, Stockholm, Sweden
Mahasti Saghatchian d'Assignies
, Institut Gustave Roussy, Dept. of Medical Oncology, Villejuif, France
Elzbieta Senkus, Medical University of Gdansk, Dept. of Oncology and Radiotherapy, Gdansk, Poland
Bostjan Seruga, Institute of Oncology Ljubljana, Dept. of Medical Oncology, Ljubljana, Slovenia
George W. Sledge, Stanford University Medical Center, Oncology Division, Stanford, USA
Petar Stefanovski, Department of Oncology and Palliative Treatment, Clinical Hospital, Bitola, Macedonia
Sandra M. Swain, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
Ian Tannock, Princess Margaret Cancer Center - University of Toronto, Dept. of Oncology and Hematology, Toronto, Canada

Ines Vaz-Luis, Gustave Roussy Institute, Molecular Medicine Dpt., Villejuif, France
Daniel A. Vorobiof
, Sandton Oncology Centre, Johannesburg, South Africa
Eric Paul Winer, Dana-Farber Cancer Institute, Breast Oncology Center, Boston, USA
Christoph Zielinski, Comprehensive Cancer Center Vienna, Clinical Division of Oncology, Vienna, Austria

PATHOLOGY
Rolando Camacho-Rodriguez, IAEA Programme of Action for Cancer Therapy (PACT), Programme Office, Wien, Austria
Gabor Cserni, Bacs-Kiskun County Teaching Hospital/University of Szeged, Dept. of Pathology, Kecskemet, Hungary
Ermina Iljazovic, University Clinical Center Tuzla, Dept. of Pathology, Tuzla, Bosnia and Herzegovina
Frédérique Penault-Llorca, Centre Jean Perrin, Department of Pathology, Clermont-Ferrand, France
Giancarlo Pruneri, University of Milan - Istituto Europeo di Oncologia, Dept. of Pathology - Biobank for Translational Medicine Dpt., Milano, Italy
Giuseppe Viale, European Institute of Oncology, Department of Pathology, University of Milan, Milano, Italy

PSYCHOLOGY
Gabriella Bianchi Micheli, Centro Senologia Svizzera Italiana CSSI, Oncology Dpt., Viganello, Switzerland

PUBLIC HEALTH
Antonis Antoniou, University of Cambridge, Public Health and Primary care, Cambrideg, United Kingdom
Banu Arun, University of Texas MD Anderson Cancer Center, Breast Medical Oncology and Clinical Cancer Genetics Dpt. Houston, USA
Peter Boyle, iPRI - International Prevention Research Institute, President, Ecully, France
Eduardo Cazap, Latinamerican & Caribbean Society of Medical Oncology, Buenos Aires, Argentina
Mike Clarke, Queen's University Belfast, Centre for Public Health, Belfast, United Kingdom
Jack Cuzick, Queen Mary University of London, Wolfson Institute of Preventive Medicine, Centre for Cancer Prevention, London, United Kingdom
Andrea De Censi, E.O. Ospedali Galliera, S.C. Oncologia Medica e Preventiva, Genova, Italy
Harry de Koning, Erasmus MC, Public Health Dpt., Rotterdam, The Netherlands
Christophorus de Wolf
, Development and evaluation of health politics (ADSAN), Geneva, Switzerland
Patricia Ganz, Jonsson Comprehensive Cancer Center - DCPCR, Dept. of Health Policy and Management, Los Angeles, USA
Livia Giordano, S. Giovanni Battista Hospital and Turin University, Unit of Epidemiology, CPO Piemonte, Turin, Italy
Nehmat Houssami, University of Sydney, Sydney Medical School, Sydney, Australia
V. Craig Jordan, University of Texas M.D. Anderson Cancer Center, Breast Medical Oncology Dpt / Molecular and Cellular Oncology Dpt., Houston, USA
Ann O'Doherty, St Vincent's Hospital, BreastCheck Merrion Screening Unit , Dublin 4, Ireland

RADIATION ONCOLOGY
John Armstrong, St. Luke's Hospital, Dept. of Radiation Oncology, Dublin 6, Ireland
Jacques Bernier
, Swiss Medical Network, Dept. of Radio-Oncology, Genolier, Switzerland
Felipe A. Calvo, Hospital General Universitario Gregorio Marañon, Dept. of Oncology, Madrid, Spain
Raphael Catane, Sheba Medical Centre, Dept. of Oncology, Ramat Gan, Israel
Pierfrancesco Franco, University of Torino, School of Medicine, Radiation Oncology Dpt., Torino, Italy
Fady B. Geara
, American University of Beirut Medical Center, Dept. of Radiation Oncology, Riad El Solh, Beirut, Lebanon
Jacek Jassem, Medical University of Gdansk, Department of Oncology & Radiotherapy, Gdansk, Poland
Barbara Jereczek, European Institute of Oncology, Div. of Radiotherapy, Milano, Italy
Roberto Orecchia, Istituto Europeo di Oncologia, Dept. Radiotherapy, Milano, Italy
Philip Poortmans, Institut Curie, Radiation Oncology Dpt, Paris, France
Antonella Richetti, Oncology Institute of the Southern Switzerland (IOSI), Radiation Oncology Dpt., Bellinzona, Switzerland
Eduard Vrdoljak, Clinical Hospital Split, Medical School Split    Clinic of Oncology and radiotherapy, Split, Croatia

RADIOLOGY
Tanja Gagliardi, Aberdeen Royal Infirmary, Dept. of Clinical Radiology, Aberdeen, United Kingdom
Pietro Panizza, IRCCS Ospedale San Raffaele, Breast Imaging, Milano, Italy
Marco Rosselli Del Turco, Roma, Italy

SURGICAL ONCOLOGY
Riccardo A. Audisio, St Helens Hospital - University of Liverpool, Dept. of Surgery, St Helens, United Kingdom
Rajendra Badwe, Tata Memorial Hospital, Dept. of Surgical Oncology, Mumbai, India
Bettina Ballardini, Istituto Europeo di Oncologia, Surgical Senology Dpt., Milano, Italy
Maria-João Cardoso, Champalimaud Foundation, Breast Unit, Lisbon, Portugal
Alberto Costa, European School of Oncology, Scientific Director Office, Milano, Italy
Iskra Daskalova, European Medical Centre, Breast Clinic    Moscow, Russian Federation
Radan Dzodic, Institute of Oncology and Radiology of Serbia, University of Dept. of Surgical Oncology IORS, Belgrade, Serbia
Antonio Frasson, Breast Group, Oncological Center, Albert Einstein Hospital, São Paulo, Brazil
Wolfgang Gatzemeier, Humanitas Cancer Center, Breast Unit, Rozzano, Italy
Oreste Davide Gentilini, IRCCS Ospedale San Raffaele, Unità di Chirurgia della Mammella, Milano, Italy
James Geraghty, University College Dublin, Department Of Surgery, Dublin 4, Ireland
Bahadir M. Gulluoglu, Marmara University School of Medicine and SENATURK Turkish Academy of Senology, Istanbul, Turkey
Tibor Kovacs, Guy's and St. Thomas' Hospital, Breast Unit, London, United Kingdom
Marjut Leidenius, Helsinki University Hospital, Comprehensive Cancer Center, Breast Surgery Unit, Helsinki, Finland
Riccardo Masetti, Catholic University of Rome, Breast Center, Roma, Italy
Enda William McDermott, St. Vincent University HospitaL, Dept. of Surgery, Dublin 4, Ireland
Francesco Meani, Ospedale Regionale di Lugano, Centro di Senologia della Svizzera Italiana, Lugano, Switzerland
Richard Rainsbury, Royal Hampshire County Hospital, Oncoplastic Breast Surgery Dpt., Winchester, United Kingdom

Roman Rouzier, Insitut Curie, Service de Chirurgie, Paris, France
Emiel J. Th. Rutgers
, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Dept. of Surgery, Amsterdam, The Netherlands

Virgilio Sacchini, European Institute of Oncology, Head of breast unit, Milan, Italy and Memorial Sloan Kettering Cancer Center, Surgery Dpt., New York, USA
Cornelis van de Velde
, Leiden University Medical Center, Dept. of Surgery, Leiden, The Netherlands
Wojciech Wysocki, Maria Sklodowska-Curie Memorial Institute Of Oncology, Dept. of Surgical Oncology, Kraków, Poland
Omar Zakaria Youssef, National Cancer Institute, Dept. of Surgical Oncology, Cairo, Egypt
Janez Zgajnar, Institute of Oncology Ljubljana, Dept. of Surgical Oncology, Ljubljana, Slovenia

OTHER
Alessandra Graziottin, Milano, Italy, Sexology

 
  CANCER GENETICS
  Back to top
Antonis Antoniou, University of Cambridge, Public Health and Primary care, Cambrideg, United Kingdom
Angela Arnold
, Memorial Sloan-Kettering Cancer Center, Department of Medicine, Clinical Genetics Service, New York, USA
Banu Arun, University of Texas MD Anderson Cancer Center, Breast Medical Oncology and Clinical Cancer Genetics Dpt., Houston, USA
Joaquim Bellmunt, Dana-Farber/Brigham and Women's Cancer Center, Associate Professor, Harvard Medical School, Boston, MA, USA
Javier Benitez, CNIO - Centro Nacional de Investigaciones Oncológicas, Dept. de Genética Humana, Madrid, Spain
Frank Claessens, University of Leuven, Dept. of Cellular and Molecular Medicine, Leuven, Belgium
Romano Danesi, Università di Pisa, Dipartimento di Medicina Clinica e Sperimentale, Pisa, Italy
Rosalind Eeles, The Institute of Cancer Research, Dept. of Oncogenetics, Sutton, Surrey, United Kingdom
Enriqueta Felip, Vall d'Hebron University Hospital, Dept. of Oncology, Barcelona, Spain
Aleksandra Filipovic, London, United Kingdom
William D. Foulkes, McGill University, Dept. of Human Genetics, Montreal, Canada
Judy Garber, Dana Farber Cancer Institute, Centre for Cancer Genetics and Prevention, Boston, USA
Alessandra Gennari, Galliera Hospital, Department of Medical Oncology, Genoa, Italy
Guido Jenster, Erasmus University Medical Center, Urology Dpt., Rotterdam, The Netherlands
Pierre Laurent-Puig
, European Georges Pompidou Hospital, Dept. of Genetics, Paris, France
Ephrat Levy Lahad, Shaare Zedek Medical Center, Medical Genetics Institute, Jerusalem, Israel
Shani Paluch-Shimon, Sheba Medical Centre, Oncology Dpt., Ramat Gan, Israel
Frédérique Penault-Llorca, Centre Jean Perrin, Department of Pathology, Clermont-Ferrand, France
Giancarlo Pruneri, University of Milan - Istituto Europeo di Oncologia, Dept. of Pathology - Biobank for Translational Medicine Dpt., Milano, Italy
Mercedes Robledo, Centro Nacional de Investigaciones Oncológicas (CNIO), Grupo de Cáncer Endocrino Hereditario, Madrid, Spain
Andrea Sartore-Bianchi, Grande Ospedale Metropolitano Niguarda, Molecular Oncology Dpt. - Niguarda Cancer Center, Milano, Italy
Christos Sotiriou, Institut Jules Bordet, Free University of Bruxelles, Breast Cancer Translational Research Laboratory J.C. Heuson, Brussels, Belgium
Stephan Stilgenbauer, University of Ulm, Dept. of Internal Medicine 3, Haematology and Oncology, Ulm, Germany

 
  CANCER PREVENTION
  Back to top
Omalkhair Abulkhair, King Abdulaziz Medical City for National Guard, Dept. of Oncology, Riyadh, Saudi Arabia
Adriana Albini, IRCCS MultiMedica, Laboratorio Biologia Vascolare e Angiogenesi, Milano, Italy
Sanaa Al Sukhun, Amman, Jordan
Antonis Antoniou, University of Cambridge, Public Health and Primary care, Cambrideg, United Kingdom
Nadir Arber , The Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
Melina Arnold
, International Agency for Research on Cancer (WHO/IARC), Section of Cancer Surveillance, Lyon, France
Banu Arun
, University of Texas MD Anderson Cancer Center, Breast Medical Oncology and Clinical Cancer Genetics Dpt., Houston, USA
Francisco Javier Bosch José, Catalan Institute of Oncology, Cancer Epidemiology Research Programme, L’Hospitalet de Llobregat, Barcelona, Spain
Peter Boyle, iPRI - International Prevention Research Institute, President, Ecully, France
Paolo Bruzzi, Istituto Nazionale per la Ricerca sul Cancro, Clinical Epidemiology Dpt., Genova, Italy
Franco Cavalli, Ospedale San Giovanni, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Eduardo Cazap, Latinamerican & Caribbean Society of Medical Oncology, Buenos Aires,
Argentina
Jack Cuzick, Queen Mary University of London, Wolfson Institute of Preventive Medicine, Centre for Cancer Prevention, London, United Kingdom
Harry de Koning, Erasmus MC, Public Health Dpt., Rotterdam, The Netherlands
Christophorus de Wolf
, Development and evaluation of health politics (ADSAN), Geneva, Switzerland
Louis Denis, Oncology Centre Antwerp, Europa Uomo, Antwerp, Belgium
Margaret Foti, American Association for Cancer Research, Philadelphia, USA
William D. Foulkes, McGill University, Dept. of Human Genetics, Montreal, Canada
Silvia Franceschi, International Agency for Research on Cancer (WHO/IARC, Infections and Cancer Epidemiology Group, Lyon, France
Milo Frattini, Istituto Cantonale di Patologia, Laboratorio di Patologia Molecolare, Locarno, Switzerland
Sara Gandini, Istituto Europeao di Oncologia, Dept. of Epidemiology and Biostatistics    Milano    Italy
Patricia Ganz, Jonsson Comprehensive Cancer Center - DCPCR, Dept. of Health Policy and Management, Los Angeles, USA
Gemma Gatta, Fondazione IRCCS Istituto Nazionale dei Tumori, Unità di Epidemiologia Valutativa, Milano, Italy
Livia Giordano, S. Giovanni Battista Hospital and Turin University, Unit of Epidemiology, CPO Piemonte, Turin, Italy
Joseph Gligorov, APHP Tenon, IUC-UPMC, Sorbonne University, Dept. of Medical Oncology, Paris, France
Murat Gultekin, Turkish Ministry of Health, Cancer Control Department, Ankara, Turkey
Rema Gvamichava, Georgian National Cancer Center, Surgery Dpt., Tbilisi, Georgia
Michael Häfner, Central Hospital Bolzano, Department of Gastroenterology and Hepatology, Bolzano, Italy
Anthony Howell, Christie Oncology/Genesis Breast Cancer Prevention, Medical Oncology and Prevention Dpt., Manchester, United Kingdom
Ermina Iljazovic, University Clinical Center Tuzla, Dept. of Pathology, Tuzla, Bosnia and Herzegovina
John Ioannidis, Stanford Prevention Research Center, Stanford, USA
Ian Magrath, INCTR Int. Network for Cancer Treatment and Research, President Office, Brussels, Belgium
Jose M. Martin Moreno, Universitat de Valencia    Preventive Medicine and Public Health, Valencia, Spain
Ugo Pastorino, Istituto Nazionale per lo Studio e la Cura dei Tumori, Chirurgia Toracica, Milano, Italy
Michael Pollak, Mc Gill University, Dept. of Oncology, Montreal, Quebec, Canada

Marco Rosselli Del Turco, Roma, Italy
Dirk Schrijvers, Ziekenhuisnetwerk Antwerpen-Middelheim, Dept. of Medical Oncology, Antwerp, Belgium
Fritz Schröder, Erasmus University, Dept. of Urology, Rotterdam, The Netherlands
Peter Siersema, Radboud University Medical Center, Dept. of Gastroenterology and Hepatology, Nijmegen, The Netherlands
Michael Sporn, Dartmouth Medical School, Dept. Pharmacology and Toxicology, Hanover, USA
Paul Sugarbaker, Washington Cancer Institute, Dept. of Surgical Oncology, Washington DC, USA
Riccardo Valdagni, Fondazione IRCCS Istituto Nazionale Tumori, Prostate Cancer Programme and Division of Radiation Oncology 1, Milano, Italy
Paolo Vineis, Imperial College London, Dept. of Epidemiology and Biostatistics, London, United Kingdom
David Zaridze, Institute of Carcinogenesis, Russian N.N.Blokhin Cancer Research Centre, Institute of Carcinogenesis, Moscow, Russian Federation

 
  CANCER RESEARCH
  Back to top
Adriana Albini, IRCCS MultiMedica, Laboratorio Biologia Vascolare e Angiogenesi, Milano, Italy
Sanaa Al Sukhun, Amman, Jordan
Antonis Antoniou, University of Cambridge, Public Health and Primary care, Cambrideg, United Kingdom
Melina Arnold, International Agency for Research on Cancer (WHO/IARC), Section of Cancer SurveillancE, Lyon, France
Hatem A. Azim Jr., Innate Pharma, Medical Director, Clinical Development, Marseille, France
Rajendra Badwe, Tata Memorial Hospital    Dept. of Surgical Oncology, Mumbai, India
Joaquim Bellmunt, Dana-Farber/Brigham and Women's Cancer Center, Associate Professor, Harvard Medical School, Boston, MA, USA
Jonas Bergh, Karolinska Institute & University Hospital    Department of Oncology-Pathology, Stockholm, Sweden
Jacques Bernier, Swiss Medical Network, Dept. of Radio-Oncology, Genolier, Switzerland
Paolo Bruzzi, Istituto Nazionale per la Ricerca sul Cancro, Clinical Epidemiology Dpt., Genova, Italy
Fatima Cardoso, Champalimaud Clinical Center, Breast Unit, Lisbon, Portugal
Franco Cavalli, Ospedale San Giovanni, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Thomas Cerny, Kantonsspital, Dept. of Oncology/Hematology, St. Gallen, Switzerland
Fortunato Ciardiello, Seconda Università degli Studi di Napoli, Dip. Medico-Chirurgico di Internistica Clin. e Sperimentale, Napoli, Italy
Frank Claessens, University of Leuven, Dept. of Cellular and Molecular Medicine, Leuven, Belgium
Mike Clarke, Queen's University Belfast, Centre for Public Health, Belfast, United Kingdom
John Crown, St Vincent's University Hospital, Dept of Medical Oncology, Dublin, Ireland
Giuseppe Curigliano, European Institute of Oncology, Department of Medicine, Division of Experimental Therapeutics, Milano, Italy
Romano Danesi, Università di Pisa, Dipartimento di Medicina Clinica e Sperimentale, Pisa, Italy
Filippo De Braud, Fondazione IRCCS Istituto Nazionale Tumori, Medical Oncology Dpt., University of Milan, Milano, Italy
Andrea De Censi, E.O. Ospedali Galliera, S.C. Oncologia Medica e Preventiva, Genova, Italy
Francesco De Lorenzo, ECPC, Roma, Italy
Maurizio D'Incalci, IRSCC - Istituto Ricerche Farmacologiche Mario Negri, Dept. Of Oncology, Milano, Italy
Don Dizon, Massachusetts General Hospital Cancer Center/Harvard Medical School, Oncology Dpt., Boston, USA
Gian Paolo Dotto, University of Lausanne, Dept. of Biochemistry, Epalinges, Switzerland
Rosalind Eeles, The Institute of Cancer Research, Dept. of Oncogenetics, Sutton, Surrey, United Kingdom

Enriqueta Felip, Vall d'Hebron University Hospital, Dept. of Oncology, Barcelona, Spain
Aleksandra Filipovic, London, United Kingdom
Margaret Foti, American Association for Cancer Research, Philadelphia, USA
William D. Foulkes, McGill University, Dept. of Human Genetics, Montreal, Canada
Silvia Franceschi, International Agency for Research on Cancer (WHO/IARC), Infections and Cancer Epidemiology Group, Lyon, France
Milo Frattini, Istituto Cantonale di Patologia, Laboratorio di Patologia Molecolare, Locarno, Switzerland
Rabab Gaafar, National Cancer Institute, Medical Oncology Dpt., Cairo, Egypt
Sara Gandini, Istituto Europeao di Oncologia, Dept. of Epidemiology and Biostatistics, Milano, Italy
Alessandra Gennari, Galliera Hospital, Department of Medical Oncology, Genoa, Italy
Livia Giordano, S. Giovanni Battista Hospital and Turin University, Unit of Epidemiology, CPO Piemonte, Turin, Italy
Salvatore Grisanti, ASST Spedali Civili, Medical Oncology Dpt., Brescia, Italy
John Ioannidis, Stanford Prevention Research Center, Stanford, USA
Barbara Jereczek, European Institute of Oncology, Div. of Radiotherapy, Milano, Italy
Guido Jenster, Erasmus University Medical Center, Urology Dpt., Rotterdam, The Netherlands
V. Craig Jordan, University of Texas M.D. Anderson Cancer Center, Breast Medical Oncology Dpt / Molecular and Cellular Oncology Dpt., Houston, USA
Stein Kaasa, Oslo University Hospital, Medival Faculty, Oslo, Norway
Hussein Khaled, Cairo University, Dept. of Medical Oncology, Cairo, Egypt
Denis Lacombe, EORTC Data Center, NDDP, Brussels, Belgium
Ian Magrath, INCTR Int. Network for Cancer Treatment and Research, President Office, Brussels, Belgium
Rolf Marti, Swiss Cancer League    Scientific Office, Bern, Switzerland
Jose M. Martin Moreno, Universitat de Valencia, Preventive Medicine and Public Health, Valencia, Spain
Olivier Michielin, Lausanne University Hospital - CHUV    Dept. of Medical Oncology, Lausanne, Switzerland
Peter Naredi, Sahlgrenska University Hospital, Dept. of Surgery, Göteborg, Sweden
Pier Giuseppe Pelicci, European Institute of Oncology, Dept. of Experimental Oncology, Milan, Italy
Frédérique Penault-Llorca, Centre Jean Perrin, Department of Pathology, Clermont-Ferrand, France
Francesco Pignatti, European Medicines Agency, Scientific & Regulatory Management Department Oncology, Haematology & Diagnostics, London, United Kingdom
Herbert Michael Pinedo, Willemstad, Curacao, Netherlands, Antilles
Michael Pollak, Mc Gill University, Dept. of Oncology, Montreal, Quebec, Canada
Giancarlo Pruneri, University of Milan - Istituto Europeo di Oncologia, Dept. of Pathology - Biobank for Translational Medicine Dpt., Milano, Italy
Christian Rolfo,University Hospital Antwerp, Head of Phase I Early Clinical Trial Unit, Dir. Cllinical Trial Man Program, Edegem, Belgium
Roman Rouzier, Insitut Curie, Service de Chirurgie, Paris, France
Helene Rundqvist, Karolinska Institutet, Dept. of Cell and Molecular Biology, Stockholm, Sweden
Mahasti Saghatchian d'Assignies, Institut Gustave Roussy, Dept. of Medical Oncology, Villejuif, France
Ramon Salazar, Institut Català d'Oncologia, Servicio de Oncologia Medica, Barcelona, Spain
Andrea Sartore-Bianchi, Grande Ospedale Metropolitano Niguarda, Molecular Oncology Dpt. - Niguarda Cancer Center, Milano, Italy
Dirk Schrijvers, Ziekenhuisnetwerk Antwerpen-Middelheim, Dept. of Medical Oncology, Antwerp, Belgium
Fritz Schröder, Erasmus University, Dept. of Urology, Rotterdam, The Netherlands
Michael Seckl, Imperial College London, Hammersmith Campus, London, United Kingdom
Jalid Sehouli, Charité Medical University, Gynaecological Clinic, Berlin, Germany
Piergiorgio Solli, Presidio Ospedaliero di Forlì, U.O. Chirurgia Toracica, Forlì, Italy
Christos Sotiriou, Institut Jules Bordet, Free University of Bruxelles, Breast Cancer Translational Research Laboratory J.C. Heuson, Brussels, Belgium
Dan Stark, St James's Hospital, Dept. of Oncology, Leeds, United Kingdom
Anastasios Stathis, Oncology Institute of Southern Switzerland, Div. of Medical Oncology, Bellinzona, Switzerland
Stephan Stilgenbauer, University of Ulm, Dept. of Internal Medicine 3, Haematology and Oncology, Ulm, Germany
Richard Sullivan, Kings Health Partners, King's College, Integrated Cancer Centre, London, United Kingdom
Riccardo Valdagni, Fondazione IRCCS Istituto Nazionale Tumori, Prostate Cancer Programme and Division of Radiation Oncology 1, Milano, Italy
Alexander van Akkooi, Netherlands Cancer Institute, Dept. of Surgical Oncology, Amsterdam, The Netherlands
Cornelis van de Velde, Leiden University Medical Center, Dept. of Surgery, Leiden, The Netherlands
Yvonne Wengström, Karolinska Insitutet, Department of Neurobiology, Care Science and Society, Div of Nursing, Huddinge, Sweden
Paul Workman, The Institute of Cancer Research, London, United Kingdom
Yosef Yarden, The Weizmann Institute of Science, Dept. of Biological Regulation, Rehovot, Israel

 
 CENTRAL NERVOUS SYSTEM TUMOURS
  Back to top
PUBLIC HEALTH
Gemma Gatta, Fondazione IRCCS Istituto Nazionale dei Tumori, Unità di Epidemiologia Valutativa, Milano, Italy

RADIATION ONCOLOGY
Felipe A. Calvo, Hospital General Universitario Gregorio Marañon, Dept. of Oncology, Madrid, Spain
Gianfranco Pesce, Istituto Oncologico della Svizzera Italiana, IOSI, Div. di Radio-Oncologia, Bellinzona, Switzerland

OTHER
Michael Brada, University of Liverpool, Dept. of Molecular and Clinical Cancer Medicine, Liverpool, United Kingdom, Molecular Medicine

 
 
 CANCER OF UNKNOWN PRIMARY TUMOURS ENDOCRINE TUMOURS AND OTHERS
  Back to top
MEDICAL ONCOLOGY
Nicholas Pavlidis, Emeritus Professor, University of Ioannina and Dean, Medical School, University of Cyprus
George Pentheroudakis, Ioannina, Greece
Alfredo Berruti, ASST Spedali Civili, S.C. Oncologia Medica, Brescia, Italy
Nicola Fazio, Istituto Europeo di Oncologia, Oncologia Medica Gastrointestinale e Tumori Neuroendocrini Dpt., Milano, Italy

PUBLIC HEALTH
Gemma Gatta, Fondazione IRCCS Istituto Nazionale dei Tumori, Unità di Epidemiologia Valutativa, Milano, Italy

 
 
  GASTRO-INTESTINAL TUMOURS
  Back to top
MEDICAL ONCOLOGY
Stefano Cascinu, Università di Modena e Reggio Emilia, Dept. of Oncology/Hematology, Modena, Italy
Andrés Cervantes Ruiperez, Hospital Clinico Universitario de Valencia - INCLIVA, Oncology Dept., Valencia, Spain
Fortunato Ciardiello, Seconda Università degli Studi di Napoli, Dip. Medico-Chirurgico di Internistica Clin. e Sperimentale, Napoli, Italy
Filippo De Braud, Fondazione IRCCS Istituto Nazionale Tumori, Medical Oncology Dpt., University of Milan, Milano, Italy
Andrea De Censi, E.O. Ospedali Galliera    S.C. Oncologia Medica e Preventiva, Genova, Italy
Francesco De Lorenzo, ECPC, Roma, Italy
Massimo Di Maio, Università degli Studi di Torino, A.O. Ordine Mauriziano, Direttore, SCDU Oncologia, Torino, Italy
Nicola Fazio, Istituto Europeo di Oncologia, Oncologia Medica Gastrointestinale e Tumori Neuroendocrini Dpt., Milano, Italy
Jonas Feilchenfeldt, National Center for Cancer Care and Research NCCCR, Doha, Qatar
Aleksandra Filipovic, London, United Kingdom
Michael Häfner, Central Hospital Bolzano, Department of Gastroenterology and Hepatology, Bolzano, Italy
Smruti Koppikar, Bombay Hospital Institute of Medical Sciences, Dept. of Medical Oncology, Mumbai, India
Roberto Labianca, ASST Papa Giovanni XXIII, Cancer Center, Bergamo, Italy
Florian Lordick, University Hospital Leipzig, University Cancer Center, Leipzig, Germany
Osman Mansour, National cancer Institute, Cairo University, Dept. of Oncology, Cairo, Egypt
Markus Moehler, University Medical Center Mainz, Gastroenterology & Endosonography Dpt., Mainz, Germany
Demetris Papamichael, Bank of Cyprus Oncology Centre, Head, Dept. of Medical Oncology, Nicosia, Cyprus
George Pentheroudakis, Ioannina, Greece
Bernhard Pestalozzi, University Hospital, Oncology Clinic, Zurich, Switzerland
Razvan Popescu, Hirslanden Klinik Aarau, Tumor Center - Dept. of Medical Oncology, Aarau, Switzerland
Cornelis J.A. Punt, Academic Medical Center, University of Amsterdam, Dept. of Medical Oncology, Amsterdam, The Netherlands
Ramon Salazar, Institut Català d'Oncologia, Servicio de Oncologia Medica, Barcelona, Spain
Andrea Sartore-Bianchi, Grande Ospedale Metropolitano Niguarda, Molecular Oncology Dpt. - Niguarda Cancer Center, Milano, Italy
Hans-Joachim Schmoll, Martin Luther University, Dept. of Internal Oncology , Halle, Germany
Salvatore Siena, Grande Ospedale Metropolitano Niguarda and Università degli Studi di Milano, Niguarda Cancer Center, Milano, Italy
Petar Stefanovski, Department of Oncology and Palliative Treatment, Clinical Hospital, Bitola, Macedonia
Josep Tabernero, Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology (VHIO), Medical Oncology Dpt., Barcelona, Spain
Wojciech Wysocki
, Maria Sklodowska-Curie Memorial Institute Of Oncology, Dept. of Surgical Oncology, Kraków, Poland
Eric Van Cutsem, University Hospital Leuven, Digestive Oncology Dpt., Leuven, Belgium

PUBLIC HEALTH
Melina Arnold, International Agency for Research on Cancer (WHO/IARC), Section of Cancer Surveillance, Lyon, France
Peter Boyle, iPRI - International Prevention Research Institute, President, Ecully, France
Andrea De Censi, E.O. Ospedali Galliera    S.C. Oncologia Medica e Preventiva, Genova, Italy
Christophorus de Wolf, Development and evaluation of health politics (ADSAN), Geneva, Switzerland
Gemma Gatta, Fondazione IRCCS Istituto Nazionale dei Tumori, Unità di Epidemiologia Valutativa, Milano, Italy

ENDOSCOPY
Massimo Conio, Sanremo, Italy
Michael Häfner, St. John of God Hospital, Centre for Interventional Endoscopy and Chronic Inflammatory Bowel Diseases, Vienna, Austria
Peter Siersema, Radboud University Medical Center, Dept. of Gastroenterology and Hepatology, Nijmegen, The Netherlands

PATHOLOGY
Frédérique Penault-Llorca, Centre Jean Perrin, Department of Pathology, Clermont-Ferrand, France


RADIATION ONCOLOGY
Eduard Vrdoljak, Clinical Hospital Split, Medical School Split, Clinic of Oncology and radiotherapy, Split, Croatia
Felipe A. Calvo, Hospital General Universitario Gregorio Marañon, Dept. of Oncology, Madrid, Spain
Pierfrancesco Franco, University of Torino, School of Medicine, Radiation Oncology Dpt., Torino, Italy
Vincenzo Valentini, Policlinico Universitario A. Gemelli, Radiation Oncology Dpt., Roma, Italy
Fady B. Geara, American University of Beirut Medical Center, Dept. of Radiation Oncology, Riad El Solh, Beirut, Lebanon
Jamal Khader, King Hussein Cancer Center, Dept. of Radiation Oncology, Amman, Jordan

SURGICAL ONCOLOGY
Rema Gvamichava, Georgian National Cancer Center, Surgery Dpt., Tbilisi, Georgia
Peter Naredi, Sahlgrenska university hospital    Dept. of Surgery, Göteborg, Sweden
Paul Sugarbaker, Washington Cancer Institute, Dept. of Surgical Oncology, Washington DC, USA
Cornelis van de Velde, Leiden University Medical Center, Dept. of Surgery, Leiden, The Netherlands
Theodoor Wiggers, Amsterdam, The Netherlands

OTHER
Romano Danesi, University of Pisa, Dept. Of Clinical and sperimental medicine, Pisa, Italy, Clinical pharmacology

Milo Frattini, Istituto Cantonale di Patologia, Laboratorio di Patologia Molecolare, Locarno, Switzerland, Pharmacy
 
  GENITOURINARY CANCER
  Back to top
MEDICAL ONCOLOGY
Joaquim Bellmunt, Dana-Farber/Brigham and Women's Cancer Center, Associate Professor, Harvard Medical School, Boston, MA, USA
Alfredo Berruti, ASST Spedali Civili, S.C. Oncologia Medica, Brescia, Italy
Dominik Berthold, Centre Hospitalier Universitaire Vaudois, Medical Oncology Dpt., Lausanne, Switzerland
Giovanni Luca Ceresoli, Istituto Humanitas Gavazzeni, Div. di Oncologia Medica, Bergamo, Italy
Johann S. de Bono, The Royal Marsden Hospital, Institue of Cancer Research Sutton, United Kingdom
Andrea De Censi, E.O. Ospedali Galliera, S.C. Oncologia Medica e Preventiva, Genova, Italy
Francesco De Lorenzo, ECPC, Roma, Italy
Maria De Santis, University of Warwick, WMS - Cancer Research, Coventr, UK
Karim Fizazi
, Institut Gustave Roussy, Dept. of Cancer Medicine, Villejuif, France
Salvatore Grisanti, ASST Spedali Civili, Medical Oncology Dpt., Brescia, Italy
Alan Horwich, The Royal Marsden Hospital - Institute of Cancer Research, Dept. of Clinical Oncology, Sutton, United Kingdom
Hussein Khaled, Cairo University, Dept. of Medical Oncology, Cairo, Egypt
Sami Khatib, Arab Medical Association Against Cancer (AMAAC), Secretary General, Amman, Jordan
Nicolas Mottet, University Jean Monnet, Dept. of Urology, Saint Etienne, France
Michael Pollak, Mc Gill University, Dept. of Oncology, Montreal, Quebec, Canada
Gordon J.S. Rustin, Mount Vernon Hospital-Center for Cancer Treatment, Dept. Medical Oncology, Northwood Middlesex, United Kingdom
Dirk Schrijvers, Ziekenhuisnetwerk Antwerpen-Middelheim, Dept. of Medical Oncology, Antwerp, Belgium
Fritz Schröder, Erasmus University, Dept. of Urology, Rotterdam, The Netherlands
Bostjan Seruga, Institute of Oncology Ljubljana, Dept. of Medical Oncology, Ljubljana, Slovenia
Dan Stark, St James's Hospital, Dept. of Oncology, Leeds, United Kingdom
Cora N. Sternberg, Ospedale San Camillo Forlanini, Div. di Oncologia Medica, Roma, Italy
Ian Tannock, Princess Margaret Cancer Center - University of Toronto, Dept. of Oncology and Hematology, Toronto, Canada
Bertrand Tombal, Cliniques Universitaires Saint-Luc, Dept. of Urology, Brussels, Belgium

PATHOLOGY
Ermina Iljazovic, University Clinical Center Tuzla, Dept. of Pathology, Tuzla, Bosnia and Herzegovina

PUBLIC HEALTH
Peter Boyle, iPRI - International Prevention Research Institute, President, Ecully, France Andrea De Censi, E.O. Ospedali Galliera, S.C. Oncologia Medica e Preventiva, Genova, Italy
Harry de Koning, Erasmus MC, Public Health Dpt., Rotterdam, The Netherlands
Gemma Gatta
, Fondazione IRCCS Istituto Nazionale dei Tumori, Unità di Epidemiologia Valutativa, Milano, Italy


RADIATION ONCOLOGY
Ngwa Che Azinwi, Oncology Institue of Southern Switzerland (IOSI), Department of Radio-oncology, Bellinzona, Switzerland
Alberto Bossi, Gustave Roussy Institute, Radiation Oncology dpt., Villejuif, France
Felipe A. Calvo, Hospital General Universitario Gregorio Marañon, Dept. of Oncology, Madrid, Spain
Fady B. Geara, American University of Beirut Medical Center, Dept. of Radiation Oncology, Riad El Solh, Beirut, Lebanon
Mary Gospodarowicz, Princess Margaret Cancer Center - University of Toronto, Dept. of Radiation Oncology, Toronto, Canada
Barbara Jereczek, European Institute of Oncology, Div. of Radiotherapy, Milano, Italy
Jamal Khader, King Hussein Cancer Center, Dept. of Radiation Oncology, Amman, Jordan
Roberto Orecchia, Istituto Europeo di Oncologia, Dept. Radiotherapy, Milano, Italy
Gianfranco Pesce, Istituto Oncologico della Svizzera Italiana, IOSI, Div. di Radio-Oncologia, Bellinzona, Switzerland
Riccardo Valdagni, Fondazione IRCCS Istituto Nazionale Tumori, Prostate Cancer Programme and Division of Radiation Oncology, Milano, Italy
Paul Van Houtte, Institut Jules Bordet, Dept. of Radiation Oncology, Bruxelles, Belgium

SURGICAL ONCOLOGY
Antonio Alcaraz, Hospital Clínic, Dept. of Urology, Barcelona, Spain
Chris H. Bangma, Erasmus University Medical Center, Dept. of Urology, Rotterdam, The Netherlands
Alberto Briganti, Urological Research Institute, Ospedale San Raffaele, Dept. of Urology, Milano, Italy
Nicolas Mottet, University Jean Monnet, Dept. of Urology, Saint Etienne, France
Giario Natale Conti, Milano, Italy
Nicola Nicolai, Fondazione IRCCS Istituto Nazionale Tumori, Urology Dpt., Milano, Italy
Chris Parker, The Royal Marsden NHS Foundation Trust, Academic Urology Unit, Sutton, Surrey , United Kingdom
Karim Touijer, Memorial Sloan-Kettering Cancer Center, Dept. of Surgery, Urology Service, New York, USA
Hein Van Poppel, University Hospital Gasthuisberg, Katholieke Universiteit, Dept. of Urology, Leuven, Belgium

OTHER
Alessandra Graziottin, Milano, Italy, Sexology
Romano Danesi, University of Pisa, Dept. Of Clinical and sperimental medicine, Pisa, Italy, Clinical pharmacology
Frank Claessens, University of Leuven, Dept. of Cellular and Molecular Medicine, Leuven, Belgium, Molecular medicine
Guido Jenster, Erasmus University Medical Center, Urology Dpt., Rotterdam, The Netherlands, Basic scientist

 
  GERIATRIC ONCOLOGY
  Back to top
MEDICAL ONCOLOGY
Matti S. Aapro, Clinique de Genolier, Oncology Dpt., Genolier, Switzerland
Laura Biganzoli, Centro Oncologico "Sandro Pitigliani", Div. di Oncologia Medica, Prato, Italy
Nicolas Mottet, University Jean Monnet, Dept. of Urology, Saint Etienne, France
Demetris Papamichael, Bank of Cyprus Oncology Centre, Head, Dept. of Medical Oncology, Nicosia, Cyprus
Razvan Popescu, Hirslanden Klinik Aarau, Tumor Center - Dept. of Medical Oncology, Aarau, Switzerland
Dirk Schrijvers, Ziekenhuisnetwerk Antwerpen-Middelheim, Dept. of Medical Oncology, Antwerp, Belgium
Bostjan Seruga, Institute of Oncology Ljubljana, Dept. of Medical Oncology, Ljubljana, Slovenia

PUBLIC HEALTH
Gemma Gatta, Fondazione IRCCS Istituto Nazionale dei Tumori, Unità di Epidemiologia Valutativa, Milano, Italy

RADIATION ONCOLOGY
Barbara Jereczek, European Institute of Oncology, Div. of Radiotherapy, Milano, Italy
Roberto Orecchia, Istituto Europeo di Oncologia, Dept. Radiotherapy, Milano, Italy
Riccardo Valdagni, Fondazione IRCCS Istituto Nazionale Tumori, Prostate Cancer Programme and Division of Radiation Oncology, Milano, Italy

SURGICAL ONCOLOGY
Riccardo A. Audisio, St Helens Hospital - University of Liverpool, Dept. of Surgery, St Helens, United Kingdom
Jalid Sehouli, Charité Medical University, Gynaecological Clinic, Berlin, Germany
Alexander van Akkooi, Netherlands Cancer Institute, Dept. of Surgical Oncology, Amsterdam, The Netherlands
Cornelis van de Velde, Leiden University Medical Center, Dept. of Surgery, Leiden, The Netherlands

 
  GYNAECOLOGIC CANCER
  Back to top
MEDICAL ONCOLOGY
Stefan Aebi, Lucerne Cantonal Hospital, Dept. of Medical Oncology, Lucerne, Switzerland
Sanaa Al Sukhun, Amman, Jordan
Semir  Beslija, Institute of Oncology, University Clinical Center, Dept. of Medical Oncology, Sarajevo, Bosnia and Herzegovina
Pier Franco Conte, Istituto Oncologico Veneto, Dipartimento di Oncologia Medica, Padova, Italy
Andrea De Censi, E.O. Ospedali Galliera, S.C. Oncologia Medica e Preventiva, Genova, Italy
Paul Cornes, Comparative Outcomes Group, Bristol, UK
Don Dizon, Massachusetts General Hospital Cancer Center/Harvard Medical School  Oncology Dpt., Boston, USA
Margaret Hutka, University Hospital Southampton, Dept. of Medical Oncology, Southampton, United Kingdom
Domenica Lorusso, Fondazione IRCCS Istituto Nazionale dei Tumori, SC Chirurgia Ginecologica, Milano, Italy
Mansoor Raza Mirza, Rigshospitalet - Copenhagen University Hospital, Dept. of Oncology, Copenhagen, Denmark
Blaise Nkegoum, University Hospital Center, Pathology and Oncology Dpt., Yaounde, Cameroon
Fedro Alessandro Peccatori, European Institute of Oncology, Dept. of Fertility and Procreation in Oncology, Milano, Italy
Isabelle Ray-Coquard, Centre Léon Bérard, Dept. of Medical Oncology, Lyon, France
Gordon J.S. Rustin, Mount Vernon Hospital-Center for Cancer Treatment, Dept. Medical Oncology, Northwood Middlesex, United Kingdom
Dirk Schrijvers, Ziekenhuisnetwerk Antwerpen-Middelheim, Dept. of Medical Oncology, Antwerp, Belgium
Michael Seckl, Imperial College London, Hammersmith Campus, London, United Kingdom
Cristiana Sessa, Oncology Institute of Southern Switzerland, Div. of Medical Oncology, Bellinzona, Switzerland
Jan Baptist Vermorken, Antwerp University Hospital, Dept. of Medical Oncology, Edegem, Belgium


PATHOLOGY

Ermina Iljazovic, University Clinical Center Tuzla, Dept. of Pathology, Tuzla, Bosnia and Herzegovina
Frédérique Penault-Llorca, Centre Jean Perrin, Department of Pathology, Clermont-Ferrand, France

PUBLIC HEALTH
Francisco Javier Bosch José, Catalan Institute of Oncology, Cancer Epidemiology Research Programme, L’Hospitalet de Llobregat, Barcelona, Spain
Andrea De Censi, E.O. Ospedali Galliera, S.C. Oncologia Medica e Preventiva, Genova, Italy
Silvia Franceschi, International Agency for Research on Cancer (WHO/IARC, Infections and Cancer Epidemiology Group, Lyon, France
Gemma Gatta
, Fondazione IRCCS Istituto Nazionale dei Tumori, Unità di Epidemiologia Valutativa, Milano, Italy
Livia Giordano, S. Giovanni Battista Hospital and Turin University, Unit of Epidemiology, CPO Piemonte, Turin, Italy
Murat Gultekin, Turkish Ministry of Health, Cancer Control Department, Ankara, Turkey

RADIATION ONCOLOGY
Felipe A. Calvo, Hospital General Universitario Gregorio Marañon, Dept. of Oncology, Madrid, Spain
Fady B. Geara, American University of Beirut Medical Center, Dept. of Radiation Oncology, Riad El Solh, Beirut, Lebanon
Antonella Richetti, Oncology Institute of the Southern Switzerland (IOSI), Radiation Oncology Dpt., Bellinzona, Switzerland
Richard Pötter, Medical University Vienna, Dept. of Radiation Oncology, Vienna, Austria
Eduard Vrdoljak, Clinical Hospital Split, Medical School Split, Clinic of Oncology and radiotherapy, Split, Croatia

RADIOLOGY
Tanja Gagliardi, Aberdeen Royal Infirmary, Dept. of Clinical Radiology, Aberdeen, United Kingdom

SURGICAL ONCOLOGY
Frédéric Amant, Netherlands Cancer Institute, Amsterdam, The Netherlands
Vesna Kesic, Clinical Center of Serbia, Dept. of Obstetrics and Gynecology, Belgrade, Serbia
Rainer Kimmig, University Hospital of Essen, Clinic for Obstetrics and Gynecology, Essen, Germany

Roman Rouzier, Insitut Curie, Service de Chirurgie, Paris, France
Paul Sugarbaker
, Washington Cancer Institute, Dept. of Surgical Oncology, Washington DC, USA
Jalid Sehouli, Charité Medical University, Gynaecological Clinic, Berlin, Germany

OTHER
Maurizio D'Incalci, IRSCC - Istituto Ricerche Farmacologiche Mario Negri, Dipartimento di Oncologia, Milano, Italy, Pharmacy
Alessandra Graziottin, Milano, Italy, Sexology

 
  HEAD & NECK CANCER
  Back to top
MEDICAL ONCOLOGY
Salvatore Grisanti, ASST Spedali Civili, Medical Oncology Dpt., Brescia, Italy
Lisa Licitra, Fondazione IRCCS Istituto Nazionale dei Tumori, SC Trattamento Medico dei Tumori di Testa e Collo, Milano, Italy
Laura Deborah Locati, Fondazione IRCCS Istiuto Nazionale dei Tumori, SC Trattamento Medico dei Tumori Testa e Collo, Milano, Italy
Dirk Schrijvers, Ziekenhuisnetwerk Antwerpen-Middelheim, Dept. of Medical Oncology, Antwerp, Belgium
Marco Siano, Cantonal Hospital St. Gallen, Dept. of Oncology Haematology, St. Gallen, Switzerland
Jan Baptist Vermorken, Antwerp University Hospital, Dept. of Medical Oncology, Edegem, Belgium

PUBLIC HEALTH
Peter Boyle, iPRI - International Prevention Research Institute, President, Ecully, France
Silvia Franceschi
, International Agency for Research on Cancer (WHO/IARC, Infections and Cancer Epidemiology Group, Lyon, France
Gemma Gatta
, Fondazione IRCCS Istituto Nazionale dei Tumori, Unità di Epidemiologia Valutativa, Milano, Italy

RADIATION ONCOLOGY
Jacques Bernier, Swiss Medical Network, Dept. of Radio-Oncology, Genolier, Switzerland
Pierfrancesco Franco
, University of Torino, School of Medicine, Radiation Oncology Dpt., Torino, Italy
Fady B. Geara
, American University of Beirut Medical Center, Dept. of Radiation Oncology, Riad El Solh, Beirut, Lebanon
Vincent Gregoire, UCL Université Catholique de Louvain, Brussels, Belgium
Roberto Orecchia, Istituto Europeo di Oncologia, Dept. Radiotherapy, Milano, Italy
Antonella Richetti, Oncology Institute of the Southern Switzerland (IOSI), Radiation Oncology Dpt., Bellinzona, Switzerland
Primoz Strojan, Institute of Oncology, Dept.of Radiation Oncology, Ljubljana, Slovenia
Vincenzo Valentini, Policlinico Universitario A. Gemelli, Radiation Oncology Dpt., Roma, Italy

SURGICAL ONCOLOGY
Andreas Dietz, University Hospital Leipzig, ENT Department, Leipzig, Germany
Radan Dzodic, Institute of Oncology and Radiology of Serbia, Dept. of Surgical Oncology IORS, Belgrade, Serbia
Enda William McDermott, St. Vincent University Hospital, Dept. of Surgery, Dublin 4, Ireland

OTHER
Martin Schlumberger, Institut Gustave Roussy, Nuclear Medicine, Villejuif, France, Nuclear Medicine

 
  HAEMATOLOGIC MALIGNANCIES
  Back to top
Jane Apperley, Imperial College, Dept. of Haematology, London, United Kingdom
James O. Armitage, University of Nebraska Medical Center, Dept. of Oncology and Hematology, Omaha, USA
Dirk Arnold, CUF Hospitals Cancer Center, Dept. of Haematology and Oncology, Lisbon, Portugal
Ngwa Che Azinwi, Oncology Institue of Southern Switzerland (IOSI), Department of Radio-oncology, Bellinzona, Switzerland
Sally Barrington, St Thomas' Hospital, Nuclear Medicine PET Imaging Centre, London, United Kingdom
Francesco Bertoni, IOR Institute of Oncology Research, Lymphoma & Genomics Research Program, Bellinzona, Switzerland
Franco Cavalli, Ospedale San Giovanni, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Luca Ceriani, Istituto Oncologico della Svizzera Italiana (IOSI), Medicina Nucleare e Centro PET-CT, Bellinzona, Switzerland
Thomas Cerny, Kantonsspital, Dept. of Oncology/Hematology, St. Gallen, Switzerland
Matteo G. Della Porta, IRCCS Humanitas Research Hospital & Humanitas University    Cancer Center - Department of Hematology, Rozzano, Italy
Andrés J.M. Ferreri, San Raffaele Scientific Institute, Unit of Lymphoid Malignancies, Milano, Italy
Martin F. Fey, Universität Bern, Klinik Für Medizinische Onkologie, Berne, Switzerland
Michele Ghielmini, Oncology Institute of Southern Switzerland (IOSI), Div. of Medical Oncology, Bellinzona, Switzerland
Mary Gospodarowicz, Princess Margaret Cancer Center - University of Toronto, Dept. of Radiation Oncology, Toronto, Canada
Manuela A. Hoechstetter, Klinikum Schwabing, Klinik für Hämatologie, Onkologie, Immunologie, Palliativmed, Munich, Germany
Hussein Khaled, Cairo University, Dept. of Medical Oncology, Cairo, Egypt
Smruti Koppikar, Bombay Hospital Institute of Medical Sciences, Dept. of Medical Oncology, Mumbai, India
T. Andrew Lister, Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, St Bartholomew’s Hospital, London, United Kingdom
Heinz Ludwig, Wilhelminenspital, Dept. of Medicine and Medical Oncology, Vienna, Austria
Ian Magrath, INCTR Int. Network for Cancer Treatment and Research, President Office, Brussels, Belgium
Giampaolo Merlini, IRCCS Policlinico San Matteo Hospital, Biotechnology Research Laboratories, Amyloidosis Centre, Pavia, Italy
Blaise Nkegoum, University Hospital Center, Pathology and Oncology Dpt., Yaounde, Cameroon
Astrid Pavlovsky, Centro de Hematología Pavlovsky, Director Office, C.A. Buenos Aires, Argentina
Giancarlo Pruneri, University of Milan - Istituto Europeo di Oncologia, Dept. of Pathology - Biobank for Translational Medicine Dpt., Milano, Italy
John Seymour, Peter MacCallum Cancer Centre, Division of Cancer Medicine, Victoria, Australia
Anastasios Stathis, Oncology Institute of Southern Switzerland, Div. of Medical Oncology, Bellinzona, Switzerland
Stephan Stilgenbauer, University of Ulm, Dept. of Internal Medicine 3, Haematology and Oncology, Ulm, Germany
Julie M. Vose, University of Nebraska Medical Center, Division of Hematology/Oncology, Omaha, Nebraska, USA
Emanuele Zucca, Lodrino, Switzerland

 
  LUNG AND OTHER THORACIC TUMOURS
  Back to top
MEDICAL ONCOLOGY
Federico Cappuzzo, Director Onco-Hematology Department, AUSL Romagna, Livorno, Italy
Giovanni Luca Ceresoli, Istituto Humanitas Gavazzeni, Div. di Oncologia Medica, Bergamo, Italy
Fortunato Ciardiello, Seconda Università degli Studi di Napoli, Dip. Medico-Chirurgico di Internistica Clin. e Sperimentale, Napoli, Italy
Tanja Cufer, University Clinic Golnik, Medical Oncology Unit, Golnik, Slovenia
Angelo Delmonte
, IRCCS - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Forlì, Italy
Massimo Di Maio, Università degli Studi di Torino, A.O. Ordine Mauriziano, Direttore, SCDU Oncologia, Torino, Italy
Enriqueta Felip, Vall d'Hebron University Hospital, Dept. of Oncology, Barcelona, Spain
Aleksandra Filipovic, London, United Kingdom

Rabab Gaafar, National Cancer Institute, Medical Oncology Dpt., Cairo, Egypt
Dragana Jovanovic, University Hospital of Pulmonology, Clinical Center of Serbia, Dept. of Thoracic Oncology, Belgrade, Serbia
Sami Khatib, Arab Medical Association Against Cancer (AMAAC), Secretary General, Amman, Jordan
Giannis Mountzios, Airforce General Hospital, Dept. of Medical Oncology, Athens, Greece
Solange Peters, Centre Hospitalier Universitaire Vaudois, Dept. of Oncology, Lausanne, Switzerland
Christian Rolfo, University Hospital Antwerp, Head of Phase I Early Clinical Trial Unit, Dir. Cllinical Trial Man Program, Edegem, Belgium
Marco Siano, Cantonal Hospital St. Gallen, Dept. of Oncology Haematology, St. Gallen, Switzerland
Rolf A. Stahel, University Hospital Zurich, Cancer Center Zurich, Zurich, Switzerland
Petar Stefanovski, Department of Oncology and Palliative Treatment, Clinical Hospital, Bitola, Macedonia
Johan Vansteenkiste, University Hospitals KU Leuven, Respiratory Oncology Unit (Dpt. Resp. Medicine), Leuven, Belgium
Christoph Zielinski, Comprehensive Cancer Center Vienna, Clinical Division of Oncology, Vienna, Austria

PATHOLOGY
Keith Kerr, Aberdeen University Medical School, Pathology Dpt., Aberdeen, Scotland, UK
Frédérique Penault-Llorca
, Centre Jean Perrin, Department of Pathology, Clermont-Ferrand, France

PUBLIC HEALTH
Peter Boyle, iPRI - International Prevention Research Institute, President, Ecully, France
Harry de Koning, Erasmus MC, Public Health Dpt., Rotterdam, The Netherlands
Gemma Gatta
, Fondazione IRCCS Istituto Nazionale dei Tumori, Unità di Epidemiologia Valutativa, Milano, Italy
Paolo Vineis, Imperial College London, Dept. of Epidemiology and Biostatistics, London, United Kingdom

RADIATION ONCOLOGY
Felipe A. Calvo, Hospital General Universitario Gregorio Marañon, Dept. of Oncology, Madrid, Spain
Rafald Dziadziuszko, Medical University of Gdansk, Oncology and Radiotherapy Dpt, Gdansk, Poland
Fady B. Geara
, American University of Beirut Medical Center, Dept. of Radiation Oncology, Riad El Solh, Beirut, Lebanon
Jacek Jassem, Medical University of Gdansk, Department of Oncology & Radiotherapy, Gdansk, Poland
Barbara Jereczek, European Institute of Oncology, Div. of Radiotherapy, Milano, ItalY
Jamal Khader, King Hussein Cancer Center, Dept. of Radiation Oncology, Amman, Jordan
Paul Van Houtte, Institut Jules Bordet, Dept. of Radiation Oncology, Bruxelles, Belgium

RADIOLOGY
Michael Brada , University of Liverpool, Dept. of Molecular and Clinical Cancer Medicine, Liverpool, United Kingdom

SURGICAL ONCOLOGY
Ugo Pastorino, Istituto Nazionale per lo Studio e la Cura dei Tumori, Chirurgia Toracica, Milano, Italy
Piergiorgio Solli, Presidio Ospedaliero di Forlì, U.O. Chirurgia Toracica, Forlì, Italy
Giulia Veronesi, Humanitas Research Hospital, Surgery Dpt., Rozzano (MI), Italy

OTHER
Romano Danesi, University of Pisa, Dept. Of Clinical and sperimental medicine, Pisa, Italy, Clinical pharmacology
Milo Frattini, Istituto Cantonale di Patologia, Laboratorio di Patologia Molecolare, Locarno, Switzerland, Molecular Medicine

 
  MELANOMA
  Back to top
MEDICAL ONCOLOGY
John Crown, St Vincent's University Hospital, Dept of Medical Oncology, Dublin, Ireland
Alberto Fusi, Infection and Immunity Research Centre, St. George's University of London, Oncology Dept., London, United Kingdom
Olivier Michielin, Lausanne University Hospital - CHUV, Dept. of Medical Oncology, Lausanne, Switzerland
Marco Siano, Cantonal Hospital St. Gallen, Dept. of Oncology Haematology, St. Gallen, Switzerland
Daniel A. Vorobiof, Sandton Oncology Centre, Johannesburg, South Africa

PUBLIC HEALTH
Sara Gandini, Istituto Europeao di Oncologia, Dept. of Epidemiology and Biostatistics, Milano, Italy
Gemma Gatta, Fondazione IRCCS Istituto Nazionale dei Tumori, Unità di Epidemiologia Valutativa, Milano, Italy

SURGICAL ONCOLOGY
Radan Dzodic, Institute of Oncology and Radiology of Serbia, Dept. of Surgical Oncology IORS, Belgrade, Serbia
Alexander M.M. Eggermont, Institut Gustave Roussy, Dept. of Oncology, Villejuif, Paris, France
Enda William McDermott, St. Vincent University Hospital, Dept. of Surgery, Dublin 4, Ireland
Peter Naredi, Sahlgrenska university hospital, Dept. of Surgery, Göteborg, Sweden
Giovanni Pellacani, Università di Modena e Reggio Emilia, Dipartimento di Dermatologia, Modena, Italy
Alessandro Testori, Milano, Italy
Alexander van Akkooi, Netherlands Cancer Institute, Dept. of Surgical Oncology, Amsterdam, The Netherlands
Wojciech Wysocki, Maria Sklodowska-Curie Memorial Institute Of Oncology, Dept. of Surgical Oncology, Kraków, Poland

 
 NURSING
  Back to top
Sara Faithfull, University of Surrey, School of Health and Medical Sciences, Guilford, Surrey, United Kingdom 
Eileen Furlong
, University College Dublin - School of Nursing, Midwifery and Health Sciences Centre, Dublin 4, Ireland
Birgitte Grube, Danish Nurses OrganisatioN, Nursing Professional Unit, Roskilde, Denmark
Cristina Lacerda, Portuguese Institute of Oncology , Haemato-Oncology Dpt., Lisbon, Portugal
Anita Margulies, EONS Education Working Group, Zurich, Switzerland
Lena Sharp, Regional Cancer Centre, Karolinska Institutet, Dept.of Learning, Informatics, Management and Ethics, Stockholm-Gotland, Stockholm, Sweden
Yvonne Wengström, Karolinska Insitutet, Department of Neurobiology, Care Science and Society, Div of Nursing, Huddinge, Sweden

 
 ONCO POLICY
  Back to top
Matti S. Aapro, Clinique de Genolier, Oncology Dpt., Genolier, Switzerland
Snezana M. Bosnjak, Institute of Oncology and Radiology of Serbia, Supportive Oncology & Intensive Care Unit, Belgrade, Serbia
Rolando Camacho-Rodriguez, IAEA Programme of Action for Cancer Therapy (PACT), Programme Office, Wien, Austria
Fatima Cardoso, Champalimaud Clinical Center, Breast Unit, Lisbon, Portugal
Paolo Giovanni Casali, Fondazione IRCCS Istituto Nazionale Tumori, SC Oncologia Medica 2, Milan, Italy
Eduardo Cazap
, Latinamerican & Caribbean Society of Medical Oncology, Buenos Aires, Argentina
Pier Franco Conte, Istituto Oncologico Veneto, Dipartimento di Oncologia Medica 2, Padova, Italy
Paul Cornes, Comparative Outcomes Group, Bristol, UK
Francesco De Lorenzo, ECPC, Roma, Italy
Louis Denis, Oncology Centre Antwerp, Europa Uomo, Antwerp, Belgium
Alexandru Eniu, Cancer Institute Ion Chiricuta, Dept. of  Breast Cancer, Cluj-Napoca, Romania
Lesley Fallowfield, Brighton & Sussex Medical School, University of Sussex, SHORE-C, Brighton, United Kingdom
Margaret Foti, American Association for Cancer Research, Philadelphia, USA
Jan Geissler, CML Advocates Network, Munchen, Germany
Mary Gospodarowicz, Princess Margaret Cancer Center - University of Toronto, Dept. of Radiation Oncology, Toronto, Canada
Birgitte Grube, Danish Nurses Organisation, Nursing Professional Unit, Roskilde, Denmark
Nehmat Houssami, University of Sydney, Sydney Medical School, Sydney, Australia
Jamal Khader, King Hussein Cancer Center, Dept. of Radiation Oncology, Amman, Jordan
Claudio Lombardo, CEO of SOS Europe Srl and Director of the Organisation of the European Cancer Institutes, Genova, Italy
Rolf Marti, Swiss Cancer League, Scientific Office, Bern, Switzerland
Francesco Pignatti, European Medicines Agency, Scientific & Regulatory Management Department Oncology, Haematology & Diagnostics, London, United Kingdom
Razvan Popescu, Hirslanden Klinik Aarau, Tumor Center - Dept. of Medical Oncology, Aarau, Switzerland
Mahasti Saghatchian d'Assignies, Institut Gustave Roussy, Dept. of Medical Oncology, Villejuif, France
Richard Sullivan, Kings Health Partners, King's College, Integrated Cancer Centre, London, United Kingdom
Josep Tabernero, Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology (VHIO), Medical Oncology Dpt., Barcelona, Spain
Miri Ziv
, Israel Cancer Association, Director Office, Givatayim, Israel


 PAEDIATRIC ONCOLOGY
  Back to top
Stefan Bielack, Klinikum Stuttgart - Olgahospital, Dept. of Pediatric Oncology, Hematology, Immunology, Stuttgart, Germany
Mohammed Fawzy, National Cancer Institute, Cairo University, Dept. of Paediatric Oncology, Cairo, Egypt
Gemma Gatta, Fondazione IRCCS Istituto Nazionale dei Tumori, Unità di Epidemiologia Valutativa, Milano, Italy
Riccardo Riccardi, Policlinico Universitario A. Gemelli, Divisione di Oncologica Pediatrica, Roma, Italy
Dan Stark, St James's Hospital, Dept. of Oncology, Leeds, United Kingdom
Gilles Vassal, Institut Gustave Roussy, Dept. of Pediatric and Clinical Pharmacology Lab. 11, Villejuif, France

 
  PATIENT ADVOCACY
  Back to top
Karen Benn, Europa Donna, Deputy CEO and Head of Public Affairs, Milano, Italy
CJ (Dian) Corneliussen-James, Annapolis, MD, USA
Francesco De Lorenzo, ECPC, Roma, Italy
Louis Denis, Oncology Centre Antwerp, Europa Uomo, Antwerp, Belgium
Jan Geissler, CML Advocates Network, Munchen, Germany
Jola Gore-Booth, CEO of EuropaColon, United Kingdom
Susan Knox, Europa Donna - The European Breast Cancer Coalition, Milan, Italy
Stella Kyriakides, Europa Donna Cyprus, Organisation Dept., Nicosia, Cyprus
Rolf Marti, Swiss Cancer League, Scientific Office, Bern, Switzerland
Kathy Oliver, International Brain Tumour Alliance - IBTA, Tadworth, Surrey, United Kingdom
Evi Papadopoulos, Europa Donna Cyprus, Nicosia, Cyprus
Kathy Redmond, Redmond Consulting, Montagnola, Switzerland
Miri Ziv, Israel Cancer Association, Director Office, Givatayim, Israel

 
  PRINCIPLES OF CLINICAL TRIALS AND SYSTEMIC THERAPY
  Back to top
MEDICAL ONCOLOGY
Matti S. Aapro, Clinique de Genolier, Oncology Dpt., Genolier, Switzerland
Stefan Aebi, Lucerne Cantonal Hospital, Dept. of Medical Oncology, Lucerne, Switzerland
Jonas Bergh, Karolinska Institute & University Hospital, Department of Oncology-Pathology, Stockholm, Sweden
Jean-Yves Blay, University Claude Bernard Lyon I, Centre Léon Bérard, Dept. of Medicine, Lyon, France
David A. Cameron, The University of Edinburgh, Edinburgh Cancer Research Centre, Edinburgh, United Kingdom
Fatima Cardoso, Champalimaud Clinical Center, Breast Unit, Lisbon, Portugal
Franco Cavalli, Ospedale San Giovanni, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Thomas Cerny, Kantonsspital, Dept. of Oncology/Hematology, St. Gallen, Switzerland
Pier Franco Conte, Istituto Oncologico Veneto, Dipartimento di Oncologia Medica 2, Padova, Italy
Giuseppe Curigliano, European Institute of Oncology, Department of Medicine, Division of Experimental Therapeutics, Milano, Italy
Johann S. de Bono, The Royal Marsden Hospital, Institue of Cancer Research, Sutton, United Kingdom
Francesco De Lorenzo, ECPC, Roma, Italy
Massimo Di Maio, Università degli Studi di Torino, A.O. Ordine Mauriziano, Direttore, SCDU Oncologia, Torino, Italy
Don Dizon, Massachusetts General Hospital Cancer Center/Harvard Medical School, Oncology Dpt., Boston, USA
Elizabeth Eisenhauer, Queen's University, Dept. of Oncology, Kingston, Ontario, Canada
Alexandru Eniu, Cancer Institute Ion Chiricuta, Dept. of  Breast Cancer    Cluj-Napoca, Romania
Enriqueta Felip, Vall d'Hebron University Hospital, Dept. of Oncology, Barcelona, Spain
Martin F. Fey, Universität Bern, Klinik Für Medizinische Onkologie, Berne, Switzerland
Aleksandra Filipovic, London, United Kingdom

Rabab Gaafar, National Cancer Institute, Medical Oncology Dpt., Cairo, Egypt
Alessandra Gennari, Galliera Hospital, Department of Medical Oncology, Genoa, Italy
Joseph Gligorov, APHP Tenon, IUC-UPMC, Sorbonne University, Dept. of Medical Oncology, Paris, France
Ian Magrath, INCTR Int. Network for Cancer Treatment and Research, President Office, Brussels, Belgium
Nicolas Mottet, University Jean Monnet, Dept. of Urology, Saint Etienne, France
George Pentheroudakis, Ioannina, Greece
Cornelis J.A. Punt, Academic Medical Center, University of Amsterdam, Dept. of Medical Oncology, Amsterdam, The Netherlands
Christian Rolfo, University Hospital Antwerp, Head of Phase I Early Clinical Trial Unit, Dir. Cllinical Trial Man Program, Edegem, Belgium
Ramon Salazar, Institut Català d'Oncologia, Servicio de Oncologia Medica, Barcelona, Spain
Litière Saskia, EORTC HQ, Statistic Dpt., Brussels, Belgium
Hans-Joachim Schmoll, Martin Luther University, Dept. of Internal Oncology , Halle, Germany
Dirk Schrijvers, Ziekenhuisnetwerk Antwerpen-Middelheim, Dept. of Medical Oncology, Antwerp, Belgium
Bostjan Seruga, Institute of Oncology Ljubljana, Dept. of Medical Oncology, Ljubljana, Slovenia
Cristiana Sessa, Oncology Institute of Southern Switzerland, Div. of Medical Oncology, Bellinzona, Switzerland
Dan Stark, St James's Hospital, Dept. of Oncology, Leeds, United Kingdom
Anastasios Stathis, Oncology Institute of Southern Switzerland, Div. of Medical Oncology, Bellinzona, Switzerland
Stephan Stilgenbauer, University of Ulm, Dept. of Internal Medicine 3, Haematology and Oncology, Ulm, Germany
Josep Tabernero, Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology (VHIO), Medical Oncology Dpt., Barcelona, Spain
Ian Tannock
, Princess Margaret Cancer Center - University of Toronto, Dept. of Oncology and Hematology, Toronto, Canada
Jaap Verweij, Erasmus University Medical Centre, Dept. of Oncology, Rotterdam, The Netherlands

PATHOLOGY
Manuela A. Hoechstetter, Klinikum Schwabing , Klinik für Hämatologie, Onkologie, Immunologie, Palliativmed, Munich, Germany


PUBLIC HEALTH
Paolo Bruzzi, Istituto Nazionale per la Ricerca sul Cancro, Clinical Epidemiology Dpt., Genova, Italy
Mike Clarke, Queen's University Belfast, Centre for Public Health, Belfast, United Kingdom
Francesco Pignatti, European Medicines Agency, Scientific & Regulatory Management, Department Oncology, Haematology & Diagnostics, London, United Kingdom

SURGICAL ONCOLOGY
Rajendra Badwe, Tata Memorial Hospital, Dept. of Surgical Oncology, Mumbai, India
Alexander van Akkooi, Netherlands Cancer Institute, Dept. of Surgical Oncology, Amsterdam, The Netherlands
Cornelis van de Velde, Leiden University Medical Center, Dept. of Surgery, Leiden, The Netherlands

OTHER
Luca Chiapperino,  European School of Molecular Medicine (SEMM), Dept. of Health Sciences, Milano, Italy, Philosophy
Romano Danesi, University of Pisa, Dept. Of Clinical and sperimental medicine, Pisa, Italy, Clinical pharmacology

 
  PSYCHO-ONCOLOGY
  Back to top
Neil Aaronson, The Netherlands Cancer Institute, Divsion of Psychosocial Research and Epidemiology, Amsterdam, The Netherlands
Lara Bellardita, Fondazione IRCCS Istituto Nazionale dei Tumori, Prostate Cancer Program, Milan, Italy
Gabriella Bianchi Micheli, Centro Senologia Svizzera Italiana CSSI, Oncology Dpt., Viganello, Switzerland
Lesley Fallowfield, Brighton & Sussex Medical School, University of Sussex, SHORE-C, Brighton, United Kingdom
Gabriella Pravettoni
, Istituto Europeo di Oncologia, Divisione di Psiconcologia, Milano, Italy
Dan Stark, St James's Hospital, Dept. of Oncology, Leeds, United Kingdom
Luzia Travado, Champalimaud Cancer Center, Psycho-Oncology Unit, Lisbon, Portugal

 
 RARE TUMOURS
  Back to top
MEDICAL ONCOLOGY
Stefan Bielack, Klinikum Stuttgart - Olgahospital, Dept. of Pediatric Oncology, Hematology, Immunology, Stuttgart, Germany
Jean-Yves Blay, University Claude Bernard Lyon I, Centre Léon Bérard, Dept. of Medicine, Lyon, France
Paolo Giovanni Casali, Fondazione IRCCS Istituto Nazionale Tumori, SC Oncologia Medica 2, Milan, Italy
Thomas Cerny, Kantonsspital, Dept. of Oncology/Hematology, St. Gallen, Switzerland
Yann Le Cam, Hôpital Broussais, Plateforme Maladies Rares - Bâtiment Gaudart d'Allaines, Paris, France
Isabelle Ray-Coquard, Centre Léon Bérard, Dept. of Medical Oncology, Lyon, France
Dan Stark, St James's Hospital, Dept. of Oncology, Leeds, United Kingdom
Jaap Verweij, Erasmus University Medical Centre, Dept. of Oncology, Rotterdam, The Netherlands
Pathology
Angelo Paolo Dei Tos, Azienda ULSS9, Anatomia Patologica Dpt., Treviso, Italy

PUBLIC HEALTH
Gemma Gatta, Fondazione IRCCS Istituto Nazionale dei Tumori, Unità di Epidemiologia Valutativa, Milano, Italy

RADIATION ONCOLOGY
Felipe A. Calvo, Hospital General Universitario Gregorio Marañon, Dept. of Oncology, Madrid, Spain
Rick Haas, The Netherlands Cancer Institute, Dept. of Radiotherapy, Amsterdam, The Netherlands
Roberto Orecchia, Istituto Europeo di Oncologia, Dept. Radiotherapy, Milano, Italy
Surgical Oncology

SURGICAL ONCOLOGY
Frédéric Amant
, Netherlands Cancer Institute, Amsterdam, The Netherlands
Ugo Pastorino
, Istituto Nazionale per lo Studio e la Cura dei Tumori, Chirurgia Toracica, Milano, Italy
Jalid Sehouli, Charité Medical University, Gynaecological Clinic, Berlin, Germany
Piergiorgio Solli, Presidio Ospedaliero di Forlì, U.O. Chirurgia Toracica, Forlì, Italy
Alexander van Akkooi, Netherlands Cancer Institute, Dept. of Surgical Oncology, Amsterdam, The Netherlands
Wojciech Wysocki, Maria Sklodowska-Curie Memorial Institute Of Oncology, Dept. of Surgical Oncology, Kraków, Poland

OTHER
Maurizio D'Incalci, IRSCC - Istituto Ricerche Farmacologiche Mario Negri, Dipartimento di Oncologia, Milano, Italy, Pharmacy


 SUPPORTIVE AND PALLIATIVE CARE
  Back to top
Matti S. Aapro, Clinique de Genolier, Oncology Dpt., Genolier, Switzerland
Frédéric Amant, Netherlands Cancer Institute, Amsterdam, The Netherlands
Hatem A. Azim Jr., Innate Pharma, Medical Director, Clinical Development, Marseille, France
Gabriella Bianchi Micheli, Centro Senologia Svizzera Italiana CSSI, Oncology Dpt., Viganello, Switzerland
Giovanni Boniolo, Università di Ferrara, Dipartimento di Scienze Biomediche e Chirurgico Specialistiche, Ferrara, Italy
Snezana M. Bosnjak, Institute of Oncology and Radiology of Serbia, Supportive Oncology & Intensive Care Unit, Belgrade, Serbia
Fatima Cardoso, Champalimaud Clinical Center, Breast Unit, Lisbon, Portugal
Maria-João Cardoso, Champalimaud Foundation, Breast Unit, Lisbon, Portugal
Raphael Catane, Sheba Medical Centre, Dept. of Oncology, Ramat Gan, Israel
Guido Cavaletti, Università Milano-Bicocca, School of Medicine and Surgery, Monza, Italy
Luca Chiapperino, European School of Molecular Medicine (SEMM), Dept. of Health Sciences, Milano, Italy
Robert Coleman, Weston Park Hospital, Medical Oncology Academic Unit of Clinical Oncology, Sheffield, United Kingdom
Paul Cornes, Comparative Outcomes Group, Bristol, UK
Francesco De Lorenzo, ECPC, Roma, Italy
Don Dizon, Massachusetts General Hospital Cancer Center/Harvard Medical School, Oncology Dpt., Boston, USA
Sara Faithfull, University of Surrey, School of Health and Medical Sciences, Guilford, Surrey, United Kingdom
Lesley Fallowfield, Brighton & Sussex Medical School, University of Sussex, SHORE-C, Brighton, United Kingdom
Claudia Gamondi, IOSI, Ospedale S. Giovanni, Servizio e Unità di Cure Palliative, Bellinzona, Switzerland
Joseph Gligorov, APHP Tenon, IUC-UPMC, Sorbonne University, Dept. of Medical Oncology, Paris, France
Alessandra Graziottin, Milano, Italy
Birgitte Grube, Danish Nurses Organisation, Nursing Professional Unit, Roskilde, Denmark
Barbara Jereczek, European Institute of Oncology, Div. of Radiotherapy, Milano, Italy
Dragana Jovanovic, University Hospital of Pulmonology, Clinical Center of Serbia, Dept. of Thoracic Oncology, Belgrade, Serbia
Stein Kaasa, Oslo University Hospital, Medival Faculty, Oslo, Norway
Roberto Labianca, ASST Papa Giovanni XXIII, Cancer Center, Bergamo, Italy
Roberto Malacrida, Foundation Sasso Corbaro for Clinical Ethics and Medical Humanities, Bellinzona, Switzerland
Dror Meirow, Sheba Medical Center, Department of Obstetrics and Gynecology, IVF Unit, Ramat Gan, Israel
Edgar Mocanu, Rotunda Hospital, HARI Unit - Reproductive Medicine Dpt., Dublin 1, Ireland
Ann H. Partridge, Dana-Farber Cancer Institute, Breast Oncology Dpt., Boston, USA
Fedro Alessandro Peccatori, European Institute of Oncology, Dept. of Fertility and Procreation in Oncology, Milano, Italy
Razvan Popescu, Hirslanden Klinik Aarau, Tumor Center - Dept. of Medical Oncology, Aarau, Switzerland

Hila Raanani, Sheba Medical Center, IVF Dpt., Ramat Gan, Israel
Fausto Roila, Medical Oncology 'S. Maria' Hospital, Dept. of Oncology, Terni, Italy
Hope S. Rugo, University of California San Francisco, Breast Oncology Clinical Trials Education, San Francisco, USA
Helene Rundqvist, Karolinska Institutet, Dept. of Cell and Molecular Biology, Stockholm, Sweden
Jalid  Sehouli, Charité Medical University, Gynaecological Clinic, Berlin, Germany
Peter Siersema, Radboud University Medical Center, Dept. of Gastroenterology and Hepatology, Nijmegen, The Netherlands
Luzia Travado, Champalimaud Cancer Center, Psycho-Oncology Unit, Lisbon, Portugal
Ines Vaz-Luis, Gustave Roussy Institute, Molecular Medicine Dpt., Villejuif, France
Yvonne Wengström, Karolinska Insitutet, Department of Neurobiology, Care Science and Society, Div of Nursing
, Huddinge, Sweden
 
  TUMOUR IMMUNOLOGY AND IMMUNOTHERAPY   
  Back to top
Matti S. Aapro, Clinique de Genolier, Oncology Dpt., Genolier, Switzerland
Sanaa Al Sukhun, Amman, Jordan
Adriana Albini, IRCCS MultiMedica, Laboratorio Biologia Vascolare e Angiogenesi, Milano, Italy
Hatem A. Azim Jr., Innate Pharma, Medical Director, Clinical Development, Marseille, France
Hamdy Abdel Azim, Cairo University Cairo Oncology Center, Dept. of Clinical Oncology, Cairo, Egypt
Joaquim Bellmunt, Dana-Farber/Brigham and Women's Cancer Center, Associate Professor, Harvard Medical School, Boston, MA, USA
Jonas Bergh, Karolinska Institute & University Hospital, Department of Oncology-Pathology, Stockholm, Sweden
Stefan Bielack, Klinikum Stuttgart - Olgahospital, Dept. of Pediatric Oncology, Hematology, Immunology, Stuttgart, Germany
Giuseppe Curigliano, European Institute of Oncology, Department of Medicine, Division of Experimental Therapeutics, Milano, Italy
Romano Danesi, University of Pisa, Dept. Of Clinical and sperimental medicine, Pisa, Italy
Filippo De Braud, Fondazione IRCCS Istituto Nazionale Tumori, Medical Oncology Dpt., University of Milan, Milano, Italy
Francesco De Lorenzo, ECPC, Roma, Italy
Alexander M.M. Eggermont, Institut Gustave Roussy, Dept. of Oncology, Villejuif, Paris, France
Enriqueta Felip, Vall d'Hebron University Hospital, Dept. of Oncology, Barcelona, Spain
Aleksandra Filipovic, London, United Kingdom
Alberto Fusi, Infection and Immunity Research Centre, St. George's University of London, Oncology Dept. - Jenner Wing, London, United Kingdom
Rabab Gaafar, National Cancer Institute, Medical Oncology Dpt., Cairo, Egypt
Alberto Mantovani, Istituto Clinico Humanitas, Direzione, Rozzano, Italy
Olivier Michielin, Lausanne University Hospital - CHUV, Dept. of Medical Oncology, Lausanne, Switzerland
Markus Moehler, University Medical Center Mainz, Gastroenterology & Endosonography Dpt., Mainz, Germany
Frédérique Penault-Llorca, Centre Jean Perrin, Department of Pathology, Clermont-Ferrand, France
Solange Peters, Centre Hospitalier Universitaire Vaudois, Dept. of Oncology, Lausanne, Switzerland
Giancarlo Pruneri, University of Milan - Istituto Europeo di Oncologia, Dept. of Pathology - Biobank for Translational Medicine Dpt., Milano, Italy
Christian Rolfo, University Hospital Antwerp, Head of Phase I Early Clinical Trial Unit, Dir. Cllinical Trial Man Program, Edegem, Belgium
Hope S. Rugo, University of California San Francisco, Breast Oncology Clinical Trials Education, San Francisco, USA
Hans-Joachim Schmoll, Martin Luther University, Dept. of Internal Oncology, Halle, Germany
Marco Siano, Cantonal Hospital St. Gallen, Dept. of Oncology Haematology, St. Gallen, Switzerland
Rolf A. Stahel, University Hospital Zurich, Cancer Center Zurich, Zurich, Switzerland
Alexander van Akkooi, Netherlands Cancer Institute, Dept. of Surgical Oncology, Amsterdam, The Netherlands

 
  OTHER
  Back to top
Hamdy Abdel Azim, Cairo University Cairo Oncology Center, Dept. of Clinical Oncology, Cairo, Egypt, Bone health in cancer patients
Sanaa Al Sukhun, Amman, Jordan, Implementing evidence in limited resource environments
Giovanni Boniolo, University of Ferrara, Dept. Of Biomedic sciences and Surgery, Ferrara, Italy, Clinical ethics and humanities
Rolf Marti, Swiss Cancer League, Scientific Office, Bern, Switzerland, Drug development and pricing
Litière Saskia, EORTC HQ, Statistic Dpt., Brussels, Belgium, Biostatistics